Table 3. Expression data for the entire series: histologic subtypes and grades according to the World Health Organization.

	p14	p16	PDGF	EGFR	PTEN	VEGF	MGMT	hTERT
A II	10	10	10	10	8	8	8	10
	4.91 (0.01–28.50)	2.30 (0.15–51.27)	2.07 (0.73–9.85)	10.20 (2.64–337)	1.14 (0.65–2.00)	4.88 (1.04–15)	0.28 (0.10–1.37)	0.0002 (0–0.07)
OA II	10	10	10	10	8	10	8	10
	4.28 (1.03–45.57)	2.75 (0.12–49.87)	1.88 (0.57–11.96)	29.71 (0.97–154)	1.16 (0.01–2.57)	10.74 (2.51–154)	0.45 (0.03–1.007)	0.001 (0–0.52)
OD II	28	28	27	28	26	27	26	28
	5.91 (0.62–47.5)	5.26 (0.50–39.40)	1.74 (0.12–14.83)	12.91 (0.03–639)	1.20 (0.34–34)	7.01 (0.21–146)	0.40 (0.01–1.59)	0.001 (0–0.62)
Low-grade tumors	48	48	47	48	42	45	42	48
	5.06 (0.01–47.5)	4.39 (0.12–51.27)	1.82 (0.12–14.83)	12.91 (0.03–639)	1.17 (0.01–34)	8.00 (0.21–154)	0.40 (0.01–1.59)	0.001 (0–0.62)
A III	6	6	6	6	6	6	6	6
	1.18 (0.39–19.43)	2.43 (0.05–23821)	1.36 (0.09–42.52)	16.11 (1.72–55.33)	1.69 (0.19–5.78)	26.06 (5.98–744)	0.24 (0.13–1.97)	0.005 (0–0.02)
OA III	21	21	21	21	21	21	21	21
	1.78 (0.22–75.58)	0.56 (0.009–398)	2.11 (0.43–35.51)	8.40 (0.73–302)	1.28 (0.26–3.14)	13.00 (2.13–266)	0.20 (0.01–1.44)	0.004 (0–0.17)
OD III	35	35	35	35	34	34	34	35
	3.53 (0.19–49.42)	1.78 (0.01–195)	2.97 (0.46–13.45)	13.83 (0.92–739)	1.07 (0.09–8.22)	42.69 (1.31–272)	0.24 (0.06–5.39)	0.004 (0–0.17)
GBM	157	157	157	157	154	154	153	157
	0.91 (0.01–1488)	0.48 (0.003–23821)	2.07 (0.01–266)	11.24 (0.01–1478)	0.53 (0.33–1.13)	73.77 (0.38–1562)	0.20 (0.003–5.58)	0.01 (0–0.29)
High-grade tumors	224	224	224	224	220	220	219	224
	1.24 (0.01–1488)	0.58 (0.003–23821)	2.08 (0.01–1978)	10.44 (0.01–1478)	0.71 (0.01–8.22)	54.95 (0.38–1562)	0.21 (0.003–5.58)	0.01 (0–0.29)
Entire series	272	272	271	272	262	265	261	272
	1.73 (0.01–1488)	1.141 (0.003–23821)	1.986 (0.01–1978)	10.85 (0.01–1478)	0.79 (0.01–34)	41.07 (0.21–1562)	0.23 (0.003–5.58)	0.01 (0–0.62)

A, astrocytoma; GBM, glioblastoma II, grade II, III, grade III; OA, oligoastrocytoma; OD, oligodendroglioma.